Drug intelligence / Profile preview

Gastilox

Development stage: Unknown
Lead developer: Novum Pharma
Modality: Small Molecules
Administration: Oral

Overview

Gastilox is an over-the-counter (OTC) antacid product line developed and marketed by Novum Pharma, a Dutch pharmaceutical company. It is primarily indicated for the relief of mild gastric discomfort, including stomach aches and acid-related pain. The product is available as peppermint-flavored chewable tablets that work by chemically neutralizing excess stomach acid to calm the stomach and facilitate recovery. A specific variant, Gastilox Plus, is formulated with citronella flavor and includes the additional active ingredient dimeticone, which acts as an anti-foaming agent to treat symptoms associated with excess gastrointestinal gas and bloating. Gastilox is positioned as a leading choice for gastric relief in the European consumer health market.

Brand names: GastiloxGastilox Plus

Beyond the preview

Go deeper on Gastilox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastilox.

Explore the full profile